BTI
CNMD icon

Blue Trust Inc’s CONMED CNMD Stock Holding History

Blue Trust Inc’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
6,596
+409
+7% +$14.7K ﹤0.01% 762
2026
Q1 		$219K Buy
6,187
+2,340
+61% +$95.2K ﹤0.01% 747
2025
Q4 		$156K Sell
3,847
-2,419
-39% -$105K ﹤0.01% 861
2025
Q3 		$295K Buy
6,266
+669
+12% +$34.7K ﹤0.01% 675
2025
Q2 		$291K Buy
5,597
+457
+9% +$25.1K ﹤0.01% 638
2025
Q1 		$310K Buy
5,140
+1,702
+50% +$110K ﹤0.01% 555
2024
Q4 		$235K Buy
3,438
+317
+10% +$22.1K ﹤0.01% 587
2024
Q3 		$216K Buy
3,121
+653
+26% +$46.1K ﹤0.01% 818
2024
Q2 		$198K Buy
2,468
+370
+18% +$27K ﹤0.01% 710
2024
Q1 		$168K Buy
2,098
+608
+41% +$54.2K ﹤0.01% 561
2023
Q4 		$150K Sell
1,490
-16
-1% -$1.65K ﹤0.01% 539
2023
Q3 		$205K Buy
1,506
+1,230
+446% +$141K ﹤0.01% 427
2023
Q2 		$29K Sell
276
-3,017
-92% -$368K ﹤0.01% 900
2023
Q1 		$292K Buy
3,293
+1,294
+65% +$125K ﹤0.01% 416
2022
Q4 		$160K Buy
1,999
+1,388
+227% +$115K ﹤0.01% 530
2022
Q3 		$58K Buy
+611
New +$57.6K ﹤0.01% 696

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Blue Trust Inc's CNMD Position: Q2 2026 in Review

Blue Trust Inc increased its CONMED (CNMD) stake by 6.6% in Q2 2026, buying an estimated $14.7K and bringing the position to 6,596 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Blue Trust Inc first reported a position in CNMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $310K in Q1 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Blue Trust Inc held 6,596 shares of CONMED worth $216K as of Q2 2026.
  • Blue Trust Inc bought 409 CONMED shares in Q2 2026, an estimated $14.7K.
  • CONMED made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #762 holding.
  • Blue Trust Inc first reported a position in CONMED in Q3 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's CONMED position peaked at $310K in Q1 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.